Abiopharma

UTHR: Notification

NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients

Plataforma Designed Enzymatic Biomaterials™ projetada pela IFF é usada pela primeira vez em grande escala em aplicações de cuidados domiciliares

Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Eastman Chemical Company - Eastman CFO Willie McLain to address the Morgan Stanley 13th Annual Laguna Conference

Coherent Debuts 30kW EDGE FL Fiber Laser for Thick Sheet Cutting at FABTECH Chicago

La plateforme Designed Enzymatic Biomaterials™ d’IFF fait l’objet d’une première utilisation à grande échelle dans des applications d’entretien ménager

Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Eastman CFO Willie McLain to address the Morgan Stanley 13th Annual Laguna Conference